{"id":19352,"date":"2022-01-10T12:19:12","date_gmt":"2022-01-10T17:19:12","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19352"},"modified":"2022-01-10T12:19:13","modified_gmt":"2022-01-10T17:19:13","slug":"becerra-orders-medicare-to-reconsider-premium-hike-following-price-drop-for-biogens-aduhelm","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19352","title":{"rendered":"Becerra orders Medicare to reconsider premium hike following price drop for Biogen\u2019s Aduhelm"},"content":{"rendered":"\n<p>(By Rachel Cohrs for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>WASHINGTON \u2014 Department of Health and Human Services Secretary Xavier Becerra on Monday took the highly unusual step of ordering Medicare to reconsider a historic hike in premiums after Biogen slashed the price for its controversial Alzheimer\u2019s drug in half.  Continue reading <a href=\"https:\/\/www.statnews.com\/2022\/01\/10\/becerra-medicare-aduhelm-reconsider-price\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2022\/01\/10\/becerra-medicare-aduhelm-reconsider-price\/\">here&#8230;<\/a><\/p>\n\n\n\n<p class=\"has-text-align-center\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"21\" class=\"wp-image-4372\" style=\"width: 200px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rachel Cohrs for STAT) WASHINGTON \u2014 Department of Health and Human Services Secretary Xavier Becerra on Monday took the<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,21,6,15],"tags":[],"class_list":["post-19352","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-health-care-finance","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19352"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19352\/revisions"}],"predecessor-version":[{"id":19353,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19352\/revisions\/19353"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}